ecosystem / people / kate-hanna
Kate Hanna on the TechTO stage

Kate Hanna

Senior Director, Communications, Novo Nordisk Canada

HealthMississaugaOn TechTO stages since 2019

Kate Hanna is Senior Director of Communications at Novo Nordisk Canada and the company's Canadian spokesperson. She has spent about 15 years in communications across Canadian pharmaceutical companies. On the TechTO MarketingTO stage in 2019 she walked through how a drug maker markets an obesity treatment under Health Canada rules that forbid naming a product and its use together.

On the TechTO stage ×1

First seen on the TechTO stage in 2019. Every talk is searchable — ask the archive about Kate

In their words

I am forbidden by law to both say the name of my product and tell you what it's used for.

TechTO MarketingTO, Sep 2019 · watch at 2:01

who wants to work a job where there's a straight line? We love the dotted line. It's so fun to figure this out.

TechTO MarketingTO, Sep 2019 · watch at 10:00
A few quotes can’t cover everything Kate said on the TechTO stage. 1,600+ talks are searchable.Ask about Kate

Quick answers

What does Kate Hanna do?

She is Senior Director of Communications at Novo Nordisk Canada in Mississauga, and acts as the company's media contact on Canadian announcements about Ozempic and Wegovy.

What did Kate Hanna talk about at TechTO?

At MarketingTO in August 2019 she gave a case study on marketing a Health Canada-approved obesity treatment, and on the regulatory rules that keep pharmaceutical marketers off most of social media.

Why can't Canadian pharma companies market normally on social?

As she explained on stage, Canadian law forbids stating a product's name and what it treats in the same advertisement — so digital campaigns run as brand-name-only ads that point people to talk to a doctor.

Suggest an edit
This is you? Claim this profileAsk to be removed
Know someone who belongs here? Suggest a profile
Maintained by TechTO · facts sourced and dated · last reviewed Jul 27, 2026